BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, Abraham R, Bruninga K, Losurdo J, DeMeo M, Mobarhan S, Shapiro D, Mutlu E. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(41): 15358-15366 [PMID: 25386085 DOI: 10.3748/wjg.v20.i41.15358]
URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15358.htm
Number Citing Articles
1
Jason S. Reich, Francis A. Farraye, Sharmeel K. Wasan. Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?Digestive Diseases and Sciences 2016; 61(8) doi: 10.1007/s10620-016-4146-x
2
Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim. Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in KoreaIntestinal Research 2018; 16(4) doi: 10.5217/ir.2018.00012
3
Giovanni Casella, Fabio Ingravalle, Adriana Ingravalle, Claudio Monti, Fulvio Bonetti, Federica De Salvatore, Vincenzo Villanacci, Aurelio Limonta. Vaccination in Inflammatory Bowel Disease: Utility and Future PerspectiveGastrointestinal Disorders 2020; 2(2) doi: 10.3390/gidisord2020019
4
Webber Chan, Ennaliza Salazar, Teong Guan Lim, Wan Chee Ong, Hang Hock Shim. Vaccinations and inflammatory bowel disease – a systematic reviewDigestive and Liver Disease 2021; 53(9) doi: 10.1016/j.dld.2021.04.015
5
Hong Yang, Zhihua Ran, Meng Jin, Jia-Ming Qian. Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter StudyGut and Liver 2022; 16(5) doi: 10.5009/gnl210217
6
Patricia C Fulkerson, Kimberly Jackson, Phillip Minar, Huyen-Tran Nguyen. Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel diseaseWorld Journal of Gastroenterology 2017; 23(42): 7644-7652 doi: 10.3748/wjg.v23.i42.7644
7
Ewa Waszczuk, Karolina M. Waszczuk, Agata Mulak, Leszek Paradowski. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2016; 28(6) doi: 10.1097/MEG.0000000000000613
8
Yueh-An Lee, Hsu-Heng Yen, Yang-Yuan Chen. Serological Assessment of Hepatitis in Patients with Inflammatory Bowel Disease in Taiwan: A Retrospective Cohort AnalysisLife 2025; 15(6) doi: 10.3390/life15060893
9
Amol Prabhakar Patil, Ebby George Simon, Amit Kumar Dutta, Anjilivelil Joseph Joseph, Reuben Thomas Kurien, Sudipta Dhar Chowdhury. Prevalence of serological markers of hepatitis B in inflammatory bowel disease – Experience from a tertiary care centre in South IndiaTropical Doctor 2021; 51(3) doi: 10.1177/00494755211015571
10
Suhyun Park, Sang Hyoung Park. Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?Gut and Liver 2022; 16(5) doi: 10.5009/gnl220364
11
J.K. Yamamoto-Furusho, A. Sarmiento-Aguilar, N.N. Parra-Holguín, K.E. Bozada-Gutiérrez. Evaluación del esquema de vacunación y cuidados con relación al seguimiento y tratamiento de los pacientes con enfermedad inflamatoria intestinalRevista de Gastroenterología de México 2019; 84(1) doi: 10.1016/j.rgmx.2018.02.003
12
Ahmed Alwassief, Qasim L Abbas, Said Al Busafi, Tawfiq T Al Lawati, Khalid Al Shmusi. Transitioning Pediatric Patients with Inflammatory Bowel Disease: Key Considerations for Adult GastroenterologistsPediatric Gastroenterology, Hepatology & Nutrition 2025; 28(3) doi: 10.5223/pghn.2025.28.3.141
13
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysisIntestinal Research 2023; 21(3) doi: 10.5217/ir.2022.00094
14
Hala H. Mansour, Ayman E. Eskander, Sara M. Osman, Normeen H. Rady. Incidence of Low Seroimmunity to Hepatitis B Virus in Children with Inflammatory Bowel Disease: A Single Center ExperiencePediatric Gastroenterology, Hepatology & Nutrition 2024; 27(2) doi: 10.5223/pghn.2024.27.2.104
15
Giorgos Bamias, Spyridon Michopoulos, Evanthia Zampeli, Georgios Axiaris. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatmentWorld Journal of Gastroenterology 2021; 27(25): 3762-3779 doi: 10.3748/wjg.v27.i25.3762
16
Ciara Egan, Glen A. Doherty. Why do we need to improve monitoring of patients with inflammatory bowel disease (IBD) on biologic treatment?Expert Opinion on Biological Therapy 2019; 19(9) doi: 10.1080/14712598.2019.1615050
17
Fotios S. Fousekis, Konstantinos H. Katsanos, Vasileios I. Theopistos, Gerasimos Baltayiannis, Maria Kosmidou, Georgios Glantzounis, Leonidas Christou, Epameinondas V. Tsianos, Dimitrios K. Christodoulou. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center studyBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0967-3
18
Shuyi Feng, Saizheng Lin, Lingling Ma, Song Xu, Yan Chen. <p>Insufficient Knowledge and Vaccination Practice of Inflammatory Bowel Disease Patients in the People’s Republic of China</p>Patient Preference and Adherence 2020;  doi: 10.2147/PPA.S265346
19
Mohammad Shehab, Fatema Alrashed, Munerah Alyaseen, Zainab Safar, Tunrayo Adekunle, Ahmad Alfadhli, Talat Bessissow. Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational StudyVaccines 2024; 12(4) doi: 10.3390/vaccines12040364
20
J.K. Yamamoto-Furusho, A. Sarmiento-Aguilar, N.N. Parra-Holguín, K.E. Bozada-Gutiérrez. Evaluation of a vaccination regimen and care in relation to follow-up and treatment of patients with inflammatory bowel diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1) doi: 10.1016/j.rgmxen.2018.05.001